NCH Prism Plus 10.28 instal the new for windows

ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). reassignment ALNYLAM PHARMACEUTICALS, INC.

Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.) Filing date Publication date Priority claimed from PCT/US2004/011829 external-priority patent/WO2004094595A2/en Priority to US13/849,003 priority Critical patent/US8796436B2/en Application filed by Alnylam Pharmaceuticals Inc filed Critical Alnylam Pharmaceuticals Inc Publication of US20130211063A1 publication Critical patent/US20130211063A1/en Priority to US14/281,661 priority patent/US9394540B2/en Publication of US8796436B2 publication Critical patent/US8796436B2/en Application granted granted Critical Priority to US15/170,693 priority patent/US20160264968A1/en Priority to US15/906,908 priority patent/US10676740B2/en Priority to US16/523,411 priority patent/US11312957B2/en Priority to US17/697,685 priority patent/US20220403377A1/en Assigned to ALNYLAM PHARMACEUTICALS, INC. Original Assignee Alnylam Pharmaceuticals Inc Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.) ( en Inventor Muthiah Manoharan Venkitasamy Kesavan Kallanthottathil RAJEEV Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.) Active Application number US13/849,003 Other versions US20130211063A1

NCH Prism Plus 10.28 instal the new for windows